BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 16299790)

  • 21. Cancer of the gastroesophageal junction: combined modality therapy.
    Ilson DH
    Surg Oncol Clin N Am; 2006 Oct; 15(4):803-24. PubMed ID: 17030275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical resection with and without chemotherapy in oesophageal cancer.
    Chander S
    Lancet; 2002 Oct; 360(9340):1174; author reply 1175. PubMed ID: 12387979
    [No Abstract]   [Full Text] [Related]  

  • 23. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation.
    Gu Y; Swisher SG; Ajani JA; Correa AM; Hofstetter WL; Liao Z; Komaki RR; Rashid A; Hamilton SR; Wu TT
    Cancer; 2006 Mar; 106(5):1017-25. PubMed ID: 16456809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Neoadjuvant therapy in oesophageal cancer surgery].
    Imdahl A
    Zentralbl Chir; 2006 Apr; 131(2):105-9. PubMed ID: 16612775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Surgical adjuvant therapy of carcinoma of the thoracic esophagus].
    Kakegawa T; Yamana H; Fujita H; Shinozaki K
    Gan To Kagaku Ryoho; 1993 Jul; 20(9):1173-8. PubMed ID: 8333745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The case for routine use of adjuvant therapy in pancreatic cancer.
    Kennedy EP; Yeo CJ
    J Surg Oncol; 2007 Jun; 95(7):597-603. PubMed ID: 17230543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Radio- and chemotherapy of cancer of the esophagus].
    Tiret E
    Rev Prat; 1999 Jun; 49(11):1186-91. PubMed ID: 10416350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoadjuvant treatment in upper gastrointestinal adenocarcinomas: new paradigms from old concepts?
    Samalin E; Ychou M
    Curr Opin Oncol; 2007 Jul; 19(4):384-9. PubMed ID: 17545805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neoadjuvant chemotherapy and surgery for esophageal adenocarcinoma: prognostic value of circumferential resection margin and stratification of N1 category.
    Saha AK; Sutton C; Rotimi O; Dexter S; Sue-Ling H; Sarela AI
    Ann Surg Oncol; 2009 May; 16(5):1364-70. PubMed ID: 19252949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neoadjuvant, surgery and adjuvant chemotherapy without radiation for esophageal cancer.
    Ardalan B; Spector SA; Livingstone AS; Franceschi D; Mezentsev D; Lima M; Bowen-Wells CP; Sparling L; Avisar E; Sapp M; Rios J; Walker G; Ganjei-Azar P
    Jpn J Clin Oncol; 2007 Aug; 37(8):590-6. PubMed ID: 17704532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?
    Elsaleh H; Farrell JJ; Crane CH
    J Gastroenterol Hepatol; 2009 May; 24(5):708-10. PubMed ID: 19646012
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis.
    Chang DT; Chapman C; Shen J; Su Z; Koong AC
    Am J Clin Oncol; 2009 Aug; 32(4):405-10. PubMed ID: 19415029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative therapy in esophageal cancer.
    Ku GY; Ilson DH
    Clin Adv Hematol Oncol; 2008 May; 6(5):371-9. PubMed ID: 18516027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Phase III clinical trial for esophageal cancer using radiotherapy].
    Ogino T
    Gan To Kagaku Ryoho; 1995 Feb; 22(3):341-9. PubMed ID: 7533489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Meta-analysis of postoperative adjuvant chemotherapy for localized esophageal carcinoma].
    Huang WZ; Fu JH; Hu Y; Zhang X; Yang H
    Ai Zheng; 2006 Oct; 25(10):1303-6. PubMed ID: 17059782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The role of radiotherapy in the management of esophageal cancer].
    Serkies K; Badzio A; Jassem J
    Pol Merkur Lekarski; 2005 Mar; 18(105):332-5. PubMed ID: 15997646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controversies in the multimodality management of locally advanced esophageal cancer: evidence-based review of surgery alone and combined-modality therapy.
    Iyer R; Wilkinson N; Demmy T; Javle M
    Ann Surg Oncol; 2004 Jul; 11(7):665-73. PubMed ID: 15197012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neoadjuvant therapy for esophageal cancer: surgical considerations.
    Piraino A; Vita ML; Tessitore A; Cusumano G; Congedo MT; Margaritora S; Porziella V; Meacci E; Cesario A; Granone P
    Rays; 2006; 31(1):37-45. PubMed ID: 16999374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of neoadjuvant chemotherapy on circumferential margin positivity and its impact on prognosis in patients with resectable oesophageal cancer.
    Sujendran V; Wheeler J; Baron R; Warren BF; Maynard N
    Br J Surg; 2008 Feb; 95(2):191-4. PubMed ID: 17948302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival effect of neoadjuvant radiotherapy before esophagectomy for patients with esophageal cancer: a surveillance, epidemiology, and end-results study.
    Schwer AL; Ballonoff A; McCammon R; Rusthoven K; D'Agostino RB; Schefter TE
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):449-55. PubMed ID: 18538500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.